[Symptomatic treatment of chronic postprandial complaints with Motilium (Domperidon): results of a double-blind study].
D000328:Adult; D000368:Aged; D001562:Benzimidazoles / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D018492:Dopamine Antagonists; D004415:Dyspepsia / Q000188:drug therapy*; D004884:Eructation / Q000188:drug therapy; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000494:pharmacology / Q000627:therapeutic use*
D001562:Benzimidazoles; D018492:Dopamine Antagonists; D010880:Piperidines
Die symptomatische Behandlung chronischer postprandialer Beschwerden mit Motilium (Domperidon). Ergebnisse einer Doppelblindstudie.